Feng Lin
- Immunology top 1%
- Molecular Biology top 10%
- Pathology and Forensic Medicine top 2%
- Oncology top 10%
- Genetics top 2%
- Co-authors
- M. Edward MedofMichael G. StrainicPeter S. HeegerPeter N. LalliHong BuFengqi AnZhidan TuJohn J. Fung
- Topics
- Complement system in diseases (28 papers)Tea Polyphenols and Effects (19 papers)T-cell and B-cell Immunology (18 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Investigation
- Partner nations
- United StatesChinaNew Zealand
In The Last Decade
Feng Lin
95 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 124
- Immunology 1.9k
- Molecular Biology 815
- Pathology and Forensic Medicine 573
- Oncology 387
- Genetics 361
Countries citing papers authored by Feng Lin
This map shows the geographic impact of Feng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Lin more than expected).
Fields of papers citing papers by Feng Lin
This network shows the impact of papers produced by Feng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Lin. The network helps show where Feng Lin may publish in the future.
Co-authorship network of co-authors of Feng Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Feng Lin. A scholar is included among the top collaborators of Feng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Lin. Feng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 6 | |
| 3 | 10 | |
| 4 | 3 | |
| 5 | 8 | |
| 6 | 7 | |
| 7 | 34 | |
| 8 | 14 | |
| 9 | 10 | |
| 10 | 69 | |
| 11 | 6 | |
| 12 | 58 | |
| 13 | 0 | |
| 14 | 121 | |
| 15 | 88 | |
| 16 | 70 | |
| 17 | 91 | |
| 18 | 242 | |
| 19 | 33 | |
| 20 | 55 |
About Feng Lin
Feng Lin is a scholar working on Immunology, Biochemistry and Pathology and Forensic Medicine, having authored 99 papers that have together received 3.9k indexed citations. Recurring topics across this work include Complement system in diseases (28 papers), Tea Polyphenols and Effects (19 papers) and T-cell and B-cell Immunology (18 papers). The work is most often cited by research in Immunology (1.9k citations), Transplantation (142 citations) and Biochemistry (204 citations). Feng Lin has collaborated with scholars based in United States, China and New Zealand. Frequent co-authors include M. Edward Medof, Michael G. Strainic, Peter S. Heeger, Peter N. Lalli, Hong Bu, Fengqi An, Zhidan Tu, John J. Fung, Yan Li and Ethan M. Shevach. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.